EBI3
Interleukin-27 subunit beta
Also known as: IL27B, IL27B_HUMAN, IL35B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14213
- Gene
- EBI3
- Ensembl
- ENSG00000105246
- Chromosome
- 19
- Canonical length
- 229 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene was identified by its induced expression in B lymphocytes in response Epstein-Barr virus infection. It encodes a secreted glycoprotein belonging to the hematopoietin receptor family, and heterodimerizes with a 28 kDa protein to form interleukin 27 (IL-27). IL-27 regulates T cell and inflammatory responses, in part by activating the Jak/STAT pathway of CD4+ T cells. [provided by RefSeq, Sep 2008]
Canonical amino-acid sequenceUniProt
229 residues, UniProt reviewed canonical sequence.
>Q14213|EBI3
1 MTPQLLLALV LWASCPPCSG RKGPPAALTL PRVQCRASRY PIAVDCSWTL PPAPNSTSPV
61 SFIATYRLGM AARGHSWPCL QQTPTSTSCT ITDVQLFSMA PYVLNVTAVH PWGSSSSFVP
121 FITEHIIKPD PPEGVRLSPL AERQLQVQWE PPGSWPFPEI FSLKYWIRYK RQGAARFHRV
181 GPIEATSFIL RAVRPRARYY VQVAAQDLTD YGELSDWSLP ATATMSLGKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EBI3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 139 nTPM
Expression across tissuesHPA
Tissue
- placenta: 139 nTPM
- spleen: 33 nTPM
- lymph node: 19 nTPM
- appendix: 14 nTPM
- thymus: 8.8 nTPM
- small intestine: 8 nTPM
Single-cell type
- extravillous trophoblasts: 974 nCPM
- syncytiotrophoblasts: 442 nCPM
- kupffer cells: 220 nCPM
- migrating cytotrophoblasts: 82 nCPM
- cdc: 72 nCPM
- macrophages: 62 nCPM
Immune cell
- memory B-cell: 19 nTPM
- naive B-cell: 15 nTPM
- non-classical monocyte: 6.4 nTPM
- intermediate monocyte: 4.9 nTPM
- myeloid DC: 0.8 nTPM
- total PBMC: 0.6 nTPM
Brain region
- white matter: 9.7 nTPM
- thalamus: 9.1 nTPM
- medulla oblongata: 8.8 nTPM
- spinal cord: 6.3 nTPM
- pons: 6 nTPM
- cerebral cortex: 5.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.84
- gnomAD pLI
- 0.11
- gnomAD missense Z
- -0.28
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- humoral immune response
- positive regulation of alpha-beta T cell proliferation
- positive regulation of type II interferon production
- T cell proliferation
- T-helper 1 type immune response
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Long hematopoietin receptor, soluble alpha chain, conserved site
- Fibronectin type III
- Immunoglobulin-like fold
- Fibronectin type III superfamily
- Interleukin-11/Interleukin-27 subunit beta
- Fibronectin type III domain
- IL27B, N-terminal Fn3 domain
- IL27B N-terminal FN3 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EBI3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EBI3 as an antibody target. Whether an autoantibody or antibody against EBI3 could matter depends on whether native EBI3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EBI3 is annotated as secreted, so native EBI3 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label EBI3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...